# Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management

> **NCT02485795** · — · UNKNOWN · sponsor: **Proove Bioscience, Inc.** · enrollment: 50000 (estimated)

## Conditions studied

- Pain
- Chronic Pain
- Back Pain
- Nociceptive Pain
- Neuropathic Pain
- Musculoskeletal Pain
- Neck Pain
- Pain, Intractable

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT02485795
- **Lead sponsor:** Proove Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2017-06
- **Final completion:** 2017-08
- **Target enrollment:** 50000 (ESTIMATED)
- **Last updated:** 2017-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02485795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02485795, "Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02485795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*